Latest Oxaliplatin Stories
SEATTLE, Nov. 30 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 17 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD) today announced updated clinical data from its randomized, controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC).
THOUSAND OAKS, Calif., Nov.
NEW YORK, Nov.
DURHAM, N.C., Oct. 26 /PRNewswire/ -- In a review article published this month in The Oncologist, UNC's Dr. Richard M.
THOUSAND OAKS, Calif., Sept.
Colorectal cancer (CRC) is the second leading cause of cancer-related death in the Western world. Fortunately physicians today have an abundance of drug therapies available to improve survival length for more advanced cancer patients.
LAKE FOREST, Ill., Aug. 11 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval and launch of oxaliplatin injection in the United States.
THOUSAND OAKS, Calif., Aug.
BETHESDA, Md. and BRIDGEWATER, N.J., Aug.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.